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Exposure of the mammary gland to ionizing radiation is one of the
best-defined risk factors for breast cancer in women. Irradiation of
the breast at younger ages appears to carry a higher relative risk for
breast cancer than exposure later in life, and the excess relative
risk per Gy (ERR/Gy) seems to decrease with attained age (Baral
et al, 1977; Boice et al, 1981, 1991; Shore et al, 1986; Davis et al,
1989; Hoffman et al, 1989; Hrubec et al, 1989; Modan et al, 1989;
Tokunaga et al, 1991, 1994). Except for these observations, little is
known about ionizing radiation and interactions with other known
risk factors for breast cancer. Most of the risk factors for breast
cancer are related to endocrine status or events, such as age at
menarche, age at first birth, number of pregnancies and age at the
menopause. In particular, an early age at the first childbirth
protects against breast cancer (MacMahon et al, 1970). It has been
suggested that among Japanese women exposed to ionizing radia-
tion, a first full-term pregnancy at an early age may be protective
against radiation-related risk (Land et al, 1994). However, repro-
ductive factors and hormone use appear to act independently of
radiation exposure on the risk of breast cancer among the same
population (Goodman et al, 1997). 
We have previously presented 2 Swedish cohorts who were
treated with ionizing radiation in infancy because of haemangiomas
and an excess of breast cancer cases was observed, with a dose-
dependent ERR of 0.35 per Gy (Lundell et al, 1999). The ERR/Gy
was substantially lower than that found in several other studies. In
a separate investigation on reproduction outcome in this cohort, it
was found that the treated women deviated from the general popu-
lation by having longer education and by smoking less (Kallen
et al, 1998). There were also differences in the number of deliv-
eries in this cohort compared to numbers derived from Swedish
rates and there were fewer infants with a birth weight less than
2500 g (Kallen et al, 1998). These factors could be interpreted as
an effect of social selection, which might explain part of the excess
of breast cancer cases found. It is important to have control of
confounding factors like these, especially when the risk related to
radiation seems to be low. 
The aim of this study was to explore whether the protective effect
of early pregnancy and the number of children interact with the
effects of previous exposure to ionizing radiation of the infant breast. 
MATERIALS AND METHODS 
The cohorts and the treatment have been described in detail 
elsewhere (Lundell et al, 1999). Children were treated similarly 
in Stockholm and Gothenburg for skin haemangiomas. In
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the dose–effect response in the cohort, part of the breast cancer excess could be explained by a different fertility pattern. The estimates of
ERR/Gy for the various categories of age at first childbirth, number of children, menopausal status and ovarian dose were very similar,
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Stockholm, 9849 female children were irradiated between 1920
and 1959. Of these, 9675 children (98%) who had been treated
before the age of 18 months were known to be alive in 1958 and
they were followed up. In Gothenburg 7632 female children were
treated between 1930 and 1965. From this cohort, 7527 females
(98%) fulfilling the same criteria as the Stockholm cohort were
followed up. 
The haemangiomas were located anywhere on the body surface,
but 42% of them were located in the head and neck region and
25% in the thoracic region. The mean age at treatment was 6
months. The children received one to several treatments, with a
mean number of 1.5. 
Dosimetry 
The dosimetry has been described in detail elsewhere (Lundell,
1994). Briefly, 89% of the cases were treated with radium-226 and
in 10% external X-rays were used. Isodose curves and dose-rate
tables were used for flat radium applicators and X-ray treatments.
When radium needles were used, the dose rate was measured with
thermoluminescence dosimeters (TLD) in a phantom corre-
sponding to the size of a 6-month-old child to determine the dose
rate to different organs (Lundell, 1994). Adjustment was made for
the age of the children (Lundell, 1994). The mean breast dose was
0.29 Gy and the median dose was 0.05 Gy (range 0–35.8 Gy). 
Record linkages 
The cohorts were matched by record linkage with 5 national popu-
lation registers, taking advantage of the unique identification
number which is given to all Swedish residents. The registers
were: 
l The National Population Register, which was used to trace
individuals alive and living in Sweden at the end of the study
period, i.e. Dec 1995. 
l The Emigration Register, established in 1968, which was used
to obtain the dates of emigration up until 1995. Information
about emigrations before 1968 was obtained from local
parishes. 
l The Swedish Cause of Death Register, which was established
in 1952, which was used to obtain dates of death and under-
lying causes of death. Information on deaths occurring before
1952 was traced through the local parishes. 
l The Swedish Cancer Register (SCR), which was used to
obtain information about the occurrence and dates of breast
cancer diagnoses in the cohorts between 1958 and 1995. Since
the register started in 1958, tumours occurring before that time
were not included in the analysis. 
l The Fertility Register containing information on deliveries
from 1941 and forward was used to obtain information about
number and year of deliveries until 1995. 
Statistical methods 
Since the absorbed dose differed by breast, the risk calculations
were based on breast-years (BY). Bilateral breast cancer was
considered as 2 separate events, as in the previous study (Lundell
et al, 1999). Breast-years and tumours before 1958, the year when
the Swedish Cancer Register was established, were not included in
the analysis. To calculate standardized incidence ratios (SIR),
expected rates were obtained from the female population of the
Country of Stockholm and the West of Sweden Health Care
Region, respectively, as most patients were residents of these 2
regions. According to the population census for 1970 and 1990,
53% and 47% of the women in the Stockholm sub-cohort lived
in the Country of Stockholm. For the Gothenburg sub-cohort,
the proportions were 77% and 73%, respectively. The expected
number of cases was calculated by multiplying attained age-,
calendar period-and cohort-specific breast-years by the corre-
sponding side-specific breast cancer incidence rates and then
summed. The reference incidence rates were stratified by attained
age (0–9, 10–19, 20–24, ..., 70–74 and > 75 years of age), calendar
periods (1958–1963, 1964–1969, 1970–1975, 1976–1981,
1982–1987 and 1988–1995) and region. Side-specific reference
rates were estimated for the period 1958–1969 as this had not been
recorded in the SCR. The estimation was done assuming that the
age-and side-specific relative distributions between left and right
breast during 1958–1969 were identical to the corresponding
distributions for the period 1970–1995. The SIR was defined as
observed over expected number of cases. 
Expected numbers of births and reproduction rates in Sweden
for the years 1961–1985 were calculated using tables from the
Statistical Year-book for Sweden. 
To study dose–response and possible interactions with other
factors, Poisson regression models were fitted using the AMFIT
program of the Epicure software (Preston et al, 1988–1993). For
this analysis, the follow-up time of the individuals was grouped
according to cohort into 2 groups, fertility pattern into 5 groups
(before any pregnancy, age at first pregnancy <20 years of age,
20–24 years, 25–29 years and ³30 years), breast dose into 5 cate-
gories (<1 cGy, 1–9, 10–99, 100–999 and ³1000 cGy), attained
age into 12 categories (<20 years, 5-year intervals until age 70,
³70 years of age), and the calendar time into 5-year categories
beginning at 1 January, 1958. To the various cells thus created,
mean values were assigned (breast dose, ovarian dose, number of
children, age at first childbirth, attained age). 
In the modelling, the 5 fertility categories were also pooled into
3 categories (age at first childbirth <25 years, age at first childbirth
³25 years or no childbirth). The menopausal status, pre- or post-
menopause, was not known but the age of 50 years was used to
define the menopause. 
Inferences about dose–response relationships were based on the
multiplicative excess relative risk (ERR) models. The observed
number of cases over the cells of the table to which the models
were fitted were assumed to follow a Poisson distribution with
mean F, where F=E(a, cp, r)*f0 (g,m) (1+f1 (bd)exp[f2(...)]) and E
is the expected number of cases based on external stratified inci-
dence rates according to age (a), calendar period (cp) and region
(r). f0 models SIR unrelated to exposure for fertility pattern-related
groups (g) and menopausal status (m). As the previous study did
not show any differences between the sub-cohorts, this analysis
was performed on aggregated data from both sub-cohorts (Lundell
et al, 1999). f1 models the excess relative risk for the breast dose
(bd), and the f2 function models the effect of various possible dose
modification factors. SIR(bd) = F/E. 
In previous studies, we found SIR(bd) = 1.08(1 + 0.35bd)
(Lundell et al, 1999). As a check of the validity of the obtained
estimates of f1, the Poisson regression analyses were also repeated
using internal reference rates with stratification for attained age
and calendar period. 364 E Holmberg et al
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Parameter estimates, confidence intervals and tests were
computed by maximum likelihood methods. 
RESULTS 
The mean age at the end of follow-up was 46 years (range 30–75
years) and there were 1 263 304 BY at risk during the period
1958–1995. A total of 307 invasive breast cancers were diagnosed
in 291 women (SIR = 1.22; 95% CI 1.09–1.36). 
A total of 206 breast cancers developed before 50 years of age
(SIR = 1.08; 95% CI 0.94–1.23) and 101 cases developed at ages
above 50 years (SIR = 1.67; 95% CI 1.37–2.02, Figure 1).
Although only 4% of the BY in the analysis were after 50 years of
age, 33% of the cases occurred in this age group. 
ERR and fertility pattern 
The total number of childbirths in the cohort during the period
1961–1995 was 30 513, compared to an expected number of 31
765 (O/E = 0.96, 95% CI 0.95–0.97). Before 25 years of age 8994
childbirths occurred, whereas 12 020 were expected (O/E = 0.75,
95% CI 0.73–0.76). For ages ³25 years 21 519 childbirths were
observed, which was more than expected, 19 744 (O/E = 1.09,
95% CI 1.08–1.11). Table 1 shows a further subdivision according
to age at childbirth. 
Among nulliparous women, 62 breast cancers occurred (SIR =
1.57; 95% CI 1.21–1.99). In those with a first childbirth before the
age of 25 SIR was 0.97 (95% CI 0.81–1.16, n = 116) and in the
women with a first childbirth after 25 years of age the SIR was
1.37 (95% CI 1.15–1.63, n = 129). A further subdivision according
to age at first childbirth is given in Table 2. The subdivision of
fertility pattern into 5 categories in the backgroundterm (f0) did
not improve the fit of the ERR-model significantly compared to
using 3 categories. The incidence rates of breast cancer in women
without childbirths, or according to whether the first childbirth
occurred before or after 25 years of age, are shown in Figure 2. 
Age at first childbirth as a continuous variable with no children
as a separate variable was a significant predictor of the SIR. In this
model, the SIR for a first childbirth at the age of 20 was 0.99 (95%
CI 0.81–1.19), and it increased by 0.04 (95% CI 0.01–0.07) for
each additional year of age at the first childbirth. 
Number of children as a numerical variable also showed a signif-
icant correlation to the SIR (P = 0.0061). The SIR for nulliparous
women was 1.65 (95% CI 1.31–1.94) and decreased by 0.24 (95%
CI 0.07–0.41) for each additional child. The addition of the age at
first childbirth to this latter model or the number of childbirths to a
model containing age at first childbirth did not significantly
improve the fit. 
There was a significant interaction effect, P < 0.001, in the
background term between fertility pattern and menopausal status.
Among nulliparous women or in women with a first childbirth
after 25 years of age, SIR was almost doubled postmenopausal
compared to premenopausal (Table 3). 
ERR and dose–response modelling 
The mean breast dose in the cohort was 0.29 Gy (range 0–35.8
Gy). There was no difference in the mean breast dose between
nulliparous women (0.28 Gy), women with first childbirths before
the age of 25 years (0.29 Gy) and women having their first child-
birth after 25 years of age (0.29 Gy). Furthermore, the mean
ovarian dose was the same (0.06 Gy) in these 3 groups. The mean
dose in the affected breasts was 1.1 Gy (range 0–35.8 Gy). 
The simple linear dose–response model was SIR (bd) = 1.10
(1 + 0.33 bd). The intercept value, 1.10 (95% CI 0.97–1.24),
Table 1 Number of childbirths during 1961–1995 among the women in the
Swedish haemangioma cohort compared to the Swedish population 
Age at childbirth  Number of  Expected   Ratio (95% CI)  
(years) children number of observed/
children expected
<20 1492 2616 0.57 (0.54–0.60) 
20–24 7502 9405 0.80 (0.78–0.82) 
25–29 10634 10412 1.02 (1.00–1.04) 
³30 10885 9332 1.17 (1.14–1.19) 
All ages 30513 31765 0.96 (0.95–0.97) 
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Figure 1 Observed incidence rate of breast cancer in the cohort and
expected incidence rate calculated from age, period and regionally matched
data from the Swedish Cancer Register. The standardized incidence ratio
was 1.08 before, and 1.67 after age 50 
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Figure 2 Observed incidence rate of breast cancer in nulliparous women
(A), in women with a first childbirth before the age of 25 (B), and in those with
a first childbirth at 25 years of age or thereafter (C). For comparison, the
expected incidence rate of breast cancer calculated from age, period and
regionally matched data in the Swedish Cancer Register is given Irradiation, fertility pattern and breast cancer risk 365
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described the SIR in the cohort not related to breast dose (SIR
(bd = 0)). The coefficient of bd, 0.33 (95% CI 0.18–0.54), is the
ERR/Gy. 
Taking the fertility pattern and menopausal status into account
in the background gave the same ERR/Gy, 0.33 (95% CI
0.17–0.53). SIR (bd = 0) varied from 0.88 to 2.31 in the different
background categories (Table 3). Inclusion of these background
categories in the model significantly improved the fit of the data
(P = 0.02). 
Estimates of excess cases per unit dose and 104 breast-years
(EAR) were derived from the fitted ERR-model. There were 2.1
(95% CI 1.2–3.2) and 5.4 (95% CI 3.0–8.3) excess cases per Gy
per 104 breast-years in the attained age groups 40–49 and 50–59
years respectively. 
The percentage of cases among those who received doses in
excess of 0.01 Gy (AR0.01GY) that can be attributed to radiation was
12.4% (95% CI 6.9–18.7%). 
Poisson regression analyses without external reference rates but
with adjustment for attained age and calendar period gave iden-
tical estimates of ERR/Gy in the total group and in all analysed
subgroups 
Interaction effects of dose response 
Table 4 gives the results of the influence on the ERR/Gy of several
factors: fertility pattern, number of children, menopausal status and
ovarian dose. None of these significantly modified the dose response
nor did age at first childbirth or attained age as continuous variables. 
DISCUSSION 
Irradiation of the female breast in infancy increases the risk for breast
cancer later in life (Lundell et al, 1999). In this study there was a 22%
excess of breast cancer cases compared with expected values using
data from the counties where most of the individuals lived. This
group of exposed girls was not a representative sample of the under-
lying population with respect to age at childbirth, since they had
fewer childbirths overall and especially fewer childbirths before the
age of 25 as measured in 1961–1995 (Table 1). Part of the recorded
excess of breast cancer might be attributed to this since one of the
strongest risk factors for breast cancer is a late age at the first preg-
nancy (MacMahon et al, 1970). In our study, a first pregnancy before
the age of 25 years conferred protection against breast cancer, which
became most obvious after the age of 50 (Figure 2 and Table 3). 
It has been suggested that a childbirth at an early age could not
only protect against breast cancer but more specifically protect
against the radiation-related risk (Land et al, 1994). Although we
found no significant interaction between fertility pattern and the
ERR/Gy, the low power of the study does not exclude an interac-
tion. ERR/Gy was, however, similar in the categories of women
Table 3 Fitted statistics by age at fertility pattern (g), menopausal status (m) and breast dose (bd). The
multiplicative ERR-model SIR (g, m, bd) = f0 (g,m) (1+f1 (bd)) was used. The first SIR column is for a model
without the dose term (f1(bd)). In the second SIR column the model has the dose term included and ERR/Gy
(95% CI) was 0.33 (0.17–0.53) 
Fertility pattern Menopausal status SIR (g,a) (95% CI) SIR (g,a,bd = 0) (95% CI) 
Age at first childbirth <25 Pre- 0.98 (0.79–1.20) 0.98 (0.71–1.09) 
Age at first childbirth <25 Post- 0.97 (0.65–1.38) 0.88 (0.58–1.25) 
Age at first childbirth ³25 Pre- 1.12 (0.89–1.38) 1.01 (0.80–1.26) 
Age at first childbirth ³25 Post- 2.17 (1.62–2.81) 1.93 (1.44–2.53) 
Nulliparous Pre- 1.28 (0.92–1.73) 1.17 (0.83–1.58) 
Nulliparous Post- 2.56 (1.65–3.75) 2.31 (1.48–3.40) 
Table 2 Observed and fitted statistics by fertility pattern. The multiplicative ERR-model
SIR (g) = f0(g) was used to calculate the SIR in the different fertility categories (g) 
Age at first childbirth Breast cancer  Breast-years SIR (95% CI)
cases
Age at first childbirth <20 33 115753 1.07 (0.75–1.48) 
Age at first childbirth, 20–24 83 277559 0.94 (0.76–1.16) 
Age at first childbirth, 25–29 88 175887 1.34 (1.08–1.64) 
Age at first childbirth ³30 41 56931 1.48 (1.07–1.98) 
Nulliparous 62 637172 1.57 (1.21–2.00) 
Total 307 1263304 1.22 (1.09–1.36) 
Table 4 Modification factors for breast dose response in the multiplicative
ERR-model, SIR (g,m,bd,...) = f0(g,m)(1+f1(bd)exp(f2(...)). The term f0(g,m)
models the modification of background due to the fertility pattern (g) and
menopausal status (m). The term f1(bd) models the ERR/Gy and f2(...) the
modification factors of the dose response 
Variables in f2(...) ERR/Gy (95% CI) P value 
With no modification factor 0.33 (0.17–0.53) 
Fertility pattern, 3 categories 0.85 
Age at first childbirth <25 0.29 (0.08–0.64) 
Age at first childbirth ³25 0.31 (0.10–0.65) 
Nulliparous 0.44 (0.10–1.07) 
Number of children, 2 categories 0.58 
Nulliparous 0.44 (0.10–1.07) 
One or more child 0.30 (0.14–0.53) 
Menopausal status, 2 categories 0.16 
Pre- 0.43 (0.21–0.75) 
Post- 0.18 (-0.04–0.47) 
Ovarian dose, continuous 0.63 
Null dose 0.31 (0.15–0.56) 
Change per cGy 0.7% (-3.1%–3.0%) 366 E Holmberg et al
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divided according to fertility pattern (Table 4). 
Information about the deliveries was collected from the Swedish
Fertility Register, which was set up during the early 1960s and
contained information about all children who lived at home at that
time. All later childbirths are included in the register. This means
that in some of the oldest individuals in our study, an early preg-
nancy may have been missed. Such individuals might therefore
have been included among women without pregnancies or with a
first childbirth after the age of 25. This would reduce the differ-
ences in breast cancer rates between the 3 groups defined by the
presence of a pregnancy or by age at first childbirth. It would
possibly also reduce the power to detect interactions between the
effect of radiation and the protective effect of the age at first child-
birth on the breast cancer risk. Taken together, these factors would
tend to diminish any differences between the groups. 
The ERR/Gy tended to be lower after the age of 50 years (post-
menopausal) than before (premenopausal), although this differ-
ence was not statistically significant (P = 0.16). In many other
studies, there has also been a tendency for the relative risk to
diminish after 45–50 years of age (BEIR-V, 1990), which might
indicate that the risk for radiation-induced cancers diminish with
time since exposure. In our previous study (Lundell et al, 1999)
where we did not adjust for the fertility pattern and menopausal
status, we found no indication of flattening of the risk curve for
radiation-related breast cancer. However considering that the
overall increased SIR after age 50 may reflect the fertility pattern
in this cohort, it is possible that the effect of ionizing radiation on
the breast cancer risk decreases after the age of 50, as has been
suggested in other studies. 
In the cohort of A-bomb survivors the ERR/Sv was 4.6 among
those who were 0–4 years old at time of the bombings (Tokunaga
et al, 1994). The A-bomb survivors showed a decreasing ERR/SV
by increasing age at exposure. Thus, for the entire group of A-
bomb survivors who were 0–19 years at the time of exposure,
ERR/Sv was 2.7 and in the order of 10 times higher than that of
our cohort. It has been suggested that the protracted low dose rate
treatment as in our cohort might ameliorate the dose effect (Howe
and McLaughlin, 1996; Lundell et al, 1999). Although a relative
risk model for dose-responses in breast cancer is generally
preferred (BEIR-V, 1990), it does not entirely account for differ-
ences between cohorts with very different background incidence
levels. On the absolute scale the excess number of cases per Gy per
104 person-years were only double in the A-bomb survivors aged
0–19 years at the time of exposure (17.2) to that of our cohort
(7.8). Therefore, it is important to specify the model when
comparing estimates between populations with different baseline
rates. In conclusion, our material was probably selected for a
fertility pattern with fewer childbirths at early ages. This may
explain part of the observed excess of breast cancers, especially
after the age of 50, in this cohort of children that were exposed to
ionizing irradiation in infancy. However, the estimates of ERR/Gy
for the different categories of age at first childbirth were rather
similar and the fertility pattern did not show any significant inter-
action on the excess risk of cancer after irradiation. Obviously, the
power to detect an interaction was low, especially at attained age
over 50 years. Since only 4% of the breast-years were after this
age, further follow-up will rapidly improve the power. 
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